KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Revvity (RVTY) Research & Development (2016 - 2026)

Revvity filings provide 18 years of Research & Development readings, the most recent being $57.9 million for Q2 2026.

  • On a quarterly basis, Research & Development rose 8.0% to $57.9 million in Q2 2026 year-over-year; TTM through Apr 2026 was $220.1 million, a 10.02% increase, with the full-year FY2025 number at $215.8 million, up 9.65% from a year prior.
  • Research & Development hit $57.9 million in Q2 2026 for Revvity, roughly flat from $58.2 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $81.9 million in Q1 2023 to a low of $48.1 million in Q2 2024.
  • Median Research & Development over the past 5 years was $53.5 million (2022), compared with a mean of $55.1 million.
  • Biggest five-year swings in Research & Development: crashed 39.42% in 2023 and later grew 18.22% in 2025.
  • Revvity's Research & Development stood at $53.5 million in 2022, then fell by 7.33% to $49.6 million in 2023, then decreased by 0.78% to $49.2 million in 2024, then rose by 18.22% to $58.2 million in 2025, then decreased by 0.5% to $57.9 million in 2026.
  • The last three reported values for Research & Development were $57.9 million (Q2 2026), $58.2 million (Q4 2025), and $50.8 million (Q3 2025) per Business Quant data.